Invention Grant
- Patent Title: Biomaterial devices and topical compositions for treatment of skin abnormalities
-
Application No.: US16123986Application Date: 2018-09-06
-
Publication No.: US10758594B2Publication Date: 2020-09-01
- Inventor: Danny Qiu , Sergio Madrigal Carballo
- Applicant: Marine Essence Biosciences Corporation of USA
- Applicant Address: US CA Chino
- Assignee: Marine Essence Biosciences Corporation of USA
- Current Assignee: Marine Essence Biosciences Corporation of USA
- Current Assignee Address: US CA Chino
- Agency: Squire Patton Boggs (US) LLP
- Main IPC: A61K38/39
- IPC: A61K38/39 ; A61K31/722 ; A61K31/728 ; A61P17/02 ; A61K35/616 ; A61K9/00 ; A61K9/06 ; A61K35/618 ; A61L27/24 ; A61L27/48 ; A61L27/52 ; A61L27/20 ; A61L27/26 ; A61L27/56

Abstract:
Devices for guided tissue regeneration (GTR) include a matrix of chitosan and mutable collagenous tissue (MCT) wherein the chitosan is electrostatically bonded to the MCT to form MCT-chitosan composite material. The MCT can be isolated from invertebrate marine organisms, such as sponges, jellyfish, mollusks and echinoderms. The MCT-chitosan composite material can be formulated as a biofilm, a 3D-sponge, a hydrogel, or as an electrospun nanofiber, or the MCT-chitosan composite material can coat a biomaterial surface. The devices can include wound dressings and tissue sponges, including 3D sponges. Applications include tissue engineering and wound healing, as well as burns and other related guided tissue regeneration applications. MCT and MCT-chitosan composite material, contained in a pharmaceutically acceptable topical carrier, also has cosmeceutical applications, for treating scars, as well as skin discoloration and various pigmentation issues, including melasma/chloasma.
Public/Granted literature
- US20190388517A1 Biomaterial Devices and Topical Compositions for Treatment of Skin Abnormalities Public/Granted day:2019-12-26
Information query
IPC分类: